SHENG-NAN CHANGTsai, Chin-FengChin-FengTsaiTING TSE LINChiu, Fu-ChunFu-ChunChiuHsu, Jung-ChengJung-ChengHsuChua, Su-KiatSu-KiatChuaHSIAO-LIANG CHENGLI-TING HOPANG-SHUO HUANGJIEN-JIUN CHENCHO-KAI WUYI-CHIH WANGJUEY-JEN HWANGCHIA-TI TSAI2023-07-212023-07-212024-010929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/633979In patients with atrial fibrillation (AF) and end-stage renal disease (ESRD), oral anticoagulants are contraindicated, and left atrial appendage occlusion (LAAO) is an alternative treatment. However, the efficacy of thromboembolic prevention using LAAO in these patients has rarely been reported in Asian populations. To our knowledge, this is the first long-term LAAO study in patients with AF undergoing dialysis in Asia.enAsian; Atrial fibrillation; End-stage renal disease; Left atrial appendage occlusionjournal article10.1016/j.jfma.2023.06.016373943332-s2.0-85163544932